April 11, 2025 – Austin, Texas – BrainCheck, a leading innovator in digital cognitive health solutions, is proud to announce the addition of three new peer-reviewed publications to its growing portfolio—bringing the total number of publications to 28. These latest studies further reinforce BrainCheck’s clinical validity, accessibility across populations, and scalability in chronic care and telehealth environments.
Key Highlights from New Publications:
Adaptation of the Florida Cognitive Activities Scale for Latinx adults with chronic diseases published in Ethnicity & Health evaluated the effectiveness of BrainCheck’s platform among Spanish-speaking participants with chronic conditions.
- High Accessibility: 92% of participants completed the BrainCheck assessment via telehealth, demonstrating strong usability in remote settings.
- Language Localization: Participants successfully completed the assessment in Spanish, supporting BrainCheck’s commitment to inclusive and culturally appropriate tools.
- Clinical Utility: Performance scores were significantly lower among individuals later referred for further dementia evaluation—supporting BrainCheck’s value as an early screening tool.
Stellate Ganglion Block reduces symptoms of SARS-CoV-2-induced ME/CFS: A prospective cohort pilot study published in Fatigue: Biomedicine, Health, and Behavior
BrainCheck was used as the primary digital assessment tool within a telehealth framework, administered remotely by trained facilitators and community health partners. Highlights include:
- Remote Cognitive Testing: BrainCheck enabled seamless telehealth cognitive assessments, guiding clinical decisions such as re-screening or referral.
- Language Inclusivity: Spanish-speaking participants successfully completed assessments using localized language support.
- Clinical Alignment: BrainCheck results correlated with clinical evaluations made by neurologists and social workers, reinforcing its diagnostic reliability.
Associations between physical activity, glucose variability, and cognitive function in older adults with type 2 diabetes published in Geriatric Nursing supports BrainCheck-style cognitive assessments as valid, scalable tools in managing chronic conditions like type 2 diabetes:
- Monitoring Cognitive Change: Digital cognitive tools like BrainCheck can track cognitive shifts over time in people with T2DM.
- Integration Potential: The study’s use of continuous glucose monitoring (CGM) alongside cognitive testing points to a hybrid health model—one BrainCheck is uniquely suited to support.
- Clinical Implications: With nearly 50% of individuals with T2DM experiencing mild cognitive impairment, BrainCheck provides a timely, scalable solution for early detection and monitoring.
These publications underscore BrainCheck’s expanding role in modern healthcare—supporting diverse populations, enabling hybrid care models, and guiding evidence-based clinical decisions. With growing peer-reviewed evidence, BrainCheck continues to lead the way in digital cognitive health.
Learn more about BrainCheck’s research publications here.
About BrainCheck
BrainCheck is revolutionizing cognitive healthcare with an easy-to-use, FDA Class II digital cognitive assessment platform that works on any device. Designed to integrate seamlessly into clinical workflows, BrainCheck empowers healthcare providers to screen, assess, and monitor cognitive health efficiently. With superior UX, top-tier clinical validation, and robust EHR integrations, BrainCheck enhances care delivery and improves patient outcomes. Trusted by leading healthcare organizations and aligned with global research initiatives, BrainCheck is committed to making cognitive health a priority for patients and providers alike.
Media Contact
Hope Fowler
Marketing Manager
BrainCheck, Inc.
hope.fowler@braincheck.com
